Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Dermira, Inc. (DERM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/02/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 02/25/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/24/2020 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 6,000 shares
@ $18.75, valued at
$112.5k
Disposed/sold 10,334 options to buy
@ $16, valued at
$165.3k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| GUGGENHIME ANDREW (CFO) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 41,951 shares
@ $18.75, valued at
$786.6k
Disposed/sold 121 options to buy
@ $5.51, valued at
$664
Disposed/sold 73,287 options to buy
@ $16, valued at
$1.2M
Disposed/sold 67,240 options to buy
@ $16, valued at
$1.1M
Disposed/sold 71,250 options to buy
@ $26.37, valued at
$1.9M
Disposed/sold 71,250 options to buy
@ $33.84, valued at
$2.4M
Disposed/sold 57,000 options to buy
@ $28.25, valued at
$1.6M
Disposed/sold 65,000 options to buy
@ $7.42, valued at
$482.3k
Disposed/sold 3,562 restricted stock units
@ $0
Disposed/sold 5,700 restricted stock units
@ $0
Disposed/sold 25,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 6,000 shares
@ $18.75, valued at
$112.5k
Disposed/sold 23,275 options to buy
@ $16, valued at
$372.4k
Disposed/sold 7,758 options to buy
@ $16, valued at
$124.1k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Fust Matthew K (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 5,051 shares
@ $18.75, valued at
$94.7k
Disposed/sold 14,224 options to buy
@ $5.51, valued at
$78.4k
Disposed/sold 10,344 options to buy
@ $16, valued at
$165.5k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Lyons-Williams Lori (Chief Commercial Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 25,401 shares
@ $18.75, valued at
$476.3k
Disposed/sold 100,000 options to buy
@ $31.87, valued at
$3.2M
Disposed/sold 63,750 options to buy
@ $28.25, valued at
$1.8M
Disposed/sold 65,000 options to buy
@ $7.42, valued at
$482.3k
Disposed/sold 6,378 restricted stock units
@ $0
Disposed/sold 30,000 restricted stock units
@ $0
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Aurora Daljit Singh (Chief Scientific Affairs Off) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 30,089 shares
@ $18.75, valued at
$564.2k
Disposed/sold 67,500 options to buy
@ $31.36, valued at
$2.1M
Disposed/sold 11,500 options to buy
@ $33.84, valued at
$389.2k
Disposed/sold 28,130 options to buy
@ $28.25, valued at
$794.7k
Disposed/sold 7,040 options to buy
@ $28.25, valued at
$198.9k
Disposed/sold 50,000 options to buy
@ $6.97, valued at
$348.5k
Disposed/sold 28,000 options to buy
@ $8.05, valued at
$225.4k
Disposed/sold 6,250 restricted stock units
@ $0
Disposed/sold 574 restricted stock units
@ $0
Disposed/sold 2,814 restricted stock units
@ $0
Disposed/sold 708 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Horan Christopher (Chief Technical Ops Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 21,400 shares
@ $18.75, valued at
$401.3k
Disposed/sold 140,000 options to buy
@ $10.14, valued at
$1.4M
Disposed/sold 65,000 options to buy
@ $7.42, valued at
$482.3k
Disposed/sold 53,333 restricted stock units
@ $0
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Gifted 12,924 shares
@ $0
Gifted 10,772 shares
@ $0
Disposed/sold 3,726 shares
@ $18.75, valued at
$69.9k
Disposed/sold 16,206 shares
@ $18.75, valued at
$303.9k
Disposed/sold 110,434 options to buy
@ $0.986, valued at
$108.9k
Disposed/sold 32,758 options to buy
@ $0.986, valued at
$32.3k
Disposed/sold 103,258 options to buy
@ $1.218, valued at
$125.8k
Disposed/sold 16,332 options to buy
@ $16, valued at
$261.3k
Disposed/sold 9,528 options to buy
@ $16, valued at
$152.4k
Disposed/sold 52,500 options to buy
@ $26.37, valued at
$1.4M
Disposed/sold 48,750 options to buy
@ $33.84, valued at
$1.6M
|
|
| 02/24/2020 |
4
| CRAVES FRED B (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 6,000 shares
@ $18.75, valued at
$112.5k
Disposed/sold 3,441,075 shares
@ $18.75, valued at
$64.5M
Disposed/sold 65,572 shares
@ $18.75, valued at
$1.2M
Disposed/sold 30,000 shares
@ $18.75, valued at
$562.5k
Disposed/sold 10,334 options to buy
@ $16, valued at
$165.3k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $8.05, valued at
$161k
|
|
| 02/24/2020 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 6,000 shares
@ $18.75, valued at
$112.5k
Disposed/sold 18,275 options to buy
@ $16, valued at
$292.4k
Disposed/sold 8,620 options to buy
@ $16, valued at
$137.9k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Gifted 27,000 shares
@ $0
Disposed/sold 49,963 shares
@ $18.75, valued at
$936.8k
Disposed/sold 180,985 shares
@ $18.75, valued at
$3.4M
Disposed/sold 164,642 options to buy
@ $0.986, valued at
$162.3k
Disposed/sold 115,022 options to buy
@ $1.218, valued at
$140.1k
Disposed/sold 64,327 options to buy
@ $1.218, valued at
$78.4k
Disposed/sold 98,430 options to buy
@ $1.74, valued at
$171.3k
Disposed/sold 355,170 options to buy
@ $16, valued at
$5.7M
Disposed/sold 180,000 options to buy
@ $26.37, valued at
$4.7M
Disposed/sold 180,000 options to buy
@ $33.84, valued at
$6.1M
Disposed/sold 150,000 options to buy
@ $28.25, valued at
$4.2M
|
|
| 02/24/2020 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 6,000 shares
@ $18.75, valued at
$112.5k
Disposed/sold 20,689 options to buy
@ $23.34, valued at
$482.9k
Disposed/sold 6,896 options to buy
@ $28.82, valued at
$198.7k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Cohen David E (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 35,682 shares
@ $18.75, valued at
$669k
Disposed/sold 17,241 options to buy
@ $0.986, valued at
$17k
Disposed/sold 8,620 options to buy
@ $0.986, valued at
$8.5k
Disposed/sold 14,224 options to buy
@ $5.51, valued at
$78.4k
Disposed/sold 10,344 options to buy
@ $16, valued at
$165.5k
Disposed/sold 10,344 options to buy
@ $28.82, valued at
$298.1k
Disposed/sold 6,000 options to buy
@ $28.01, valued at
$168.1k
Disposed/sold 6,000 options to buy
@ $9.95, valued at
$59.7k
Disposed/sold 6,000 options to buy
@ $9.38, valued at
$56.3k
Disposed/sold 3,000 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Pena Luis C. (Chief Development Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 18,233 shares
@ $18.75, valued at
$341.9k
Disposed/sold 88,251 options to buy
@ $0.986, valued at
$87k
Disposed/sold 32,506 options to buy
@ $1.218, valued at
$39.6k
Disposed/sold 71,397 options to buy
@ $1.74, valued at
$124.2k
Disposed/sold 17,062 options to buy
@ $16, valued at
$273k
Disposed/sold 50,178 options to buy
@ $16, valued at
$802.8k
Disposed/sold 60,000 options to buy
@ $26.37, valued at
$1.6M
Disposed/sold 10,000 options to buy
@ $26.37, valued at
$263.7k
Disposed/sold 48,750 options to buy
@ $33.84, valued at
$1.6M
Disposed/sold 63,750 options to buy
@ $28.25, valued at
$1.8M
Disposed/sold 65,000 options to buy
@ $7.42, valued at
$482.3k
|
|
| 02/24/2020 |
4
| Griffith Christopher M. (Chief Business & Strategy Off) has filed a Form 4 on Dermira, Inc.|
Txns:
| Disposed/sold 67,242 shares
@ $18.75, valued at
$1.3M
Disposed/sold 87,990 options to buy
@ $0.986, valued at
$86.8k
Disposed/sold 33,224 options to buy
@ $1.218, valued at
$40.5k
Disposed/sold 719 options to buy
@ $1.74, valued at
$1.3k
Disposed/sold 20,869 options to buy
@ $16, valued at
$333.9k
Disposed/sold 46,371 options to buy
@ $16, valued at
$741.9k
Disposed/sold 21,560 options to buy
@ $26.37, valued at
$568.5k
Disposed/sold 18,750 options to buy
@ $33.84, valued at
$634.5k
Disposed/sold 8,000 options to buy
@ $33.84, valued at
$270.7k
Disposed/sold 48,130 options to buy
@ $28.25, valued at
$1.4M
Disposed/sold 65,000 options to buy
@ $7.42, valued at
$482.3k
|
|
| 02/24/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 0% stake in Dermira, Inc. |
| 02/20/2020 |
4
| Bald Eagle Acquisition Corp (10% Owner) has filed a Form 4 on Dermira, Inc.|
Txns:
| Bought 40,926,025 shares
@ $18.75, valued at
$767.4M
|
|
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/20/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 02/20/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/20/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligati... |
| 02/20/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/20/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/20/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|